XML 56 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Share-based Payment Arrangements
3 Months Ended
Mar. 28, 2015
Share-based Payment Arrangements
(1) Share-based Payment Arrangements

As of March 28, 2015, the Company had two employee equity incentive plans, the 2002 employee stock option and stock incentive plan (the “ESOSIP”) and the 2011 equity incentive plan (the “2011 EIP”). No further grants can be made under the ESOSIP. The Company also has a stock compensation plan for members of its Board of Directors, the 2013 Directors Stock Compensation Plan (the “2013 DSCP”). 115,000 shares of the Company’s common stock were authorized for issuance under the 2013 DSCP. The ESOSIP, 2011 EIP, and 2013 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

 

     Thirteen Weeks Ended  
     March 28,
2015
     March 29,
2014
 

Total cost of the Plans during the period

   $ 1,667       $ 1,164   

Amount of related income tax benefit recognized during the period

     (701      (614
  

 

 

    

 

 

 

Net cost of the Plans during the period

$ 966    $ 550   
  

 

 

    

 

 

 

Included in income tax benefits recognized in the thirteen-week periods ended March 28, 2015 and March 29, 2014 were income tax benefits of $160,000 and $295,000, respectively, recognized on disqualifying dispositions of the Company’s common stock by employees who obtained shares of common stock through exercises of incentive stock options.

As of March 28, 2015, there were 95,531 shares of the Company’s common stock reserved for issuance under the 2013 DSCP and 5,602,419 shares of the Company’s common stock reserved for issuance in the aggregate under the ESOSIP and 2011 EIP.

Restricted Stock Units

The fair value of a restricted stock unit (“RSU”) is determined based on the market value of the Company’s common stock on the date of grant, discounted for lack of marketability for a minimum post-vesting holding requirement. The discount rate due to lack of marketability used for RSU award grants during both thirteen-week periods ended March 28, 2015 and March 29, 2014 was 7%.

The following table summarizes information regarding the Company’s outstanding RSU awards under the Plans:

 

     Number of
RSUs
     Weighted Average
Grant Date
Fair Value
 

Outstanding at December 27, 2014

     425,630       $ 50.72   

Granted

     91,562       $ 57.97   

Vested

     (91,382    $ 51.98   
  

 

 

    

Outstanding at March 28, 2015

  425,810    $ 52.01   
  

 

 

    

Restricted stock units vest over a 3 to 5 year period based on varying metrics of growth in operating income and diluted earnings per share either from a base year, being the year immediately preceding the year of grant, or year-over-prior-year growth. At the time of grant, the maximum number of common shares available for issuance under the 2015 grant equals 200% of the number of RSUs granted. The maximum number of common shares available for issuance under grants made prior to 2015 equals 100% of the number of RSUs granted.

 

With respect to all RSU awards, the Company reports compensation expense over the life of the award based on an estimated number of shares that will vest over the life of the award, multiplied by the fair value of a RSU. The Company recognized approximately $1,158,000 and $641,000 of share-based compensation expense related to RSU awards in the thirteen-week periods ended March 28, 2015 and March 29, 2014, respectively. As of March 28, 2015, there was a maximum of $26,600,000 of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.4 years. The amount of future compensation expense to be recognized will be determined based on future operating results.

Stock Options

The following table summarizes information regarding the Company’s outstanding stock options under the Plans:

 

     Number of
Options
     Weighted Average
Exercise Price
per Share
     Weighted Average
Remaining
Contractual
Term (years)
     Aggregate Intrinsic
Value (000s)
 

Options outstanding at December 27, 2014

     773,839       $ 46.92         

Exercised

     (48,700    $ 45.52         

Forfeited

     (1,000    $ 52.60         
  

 

 

          

Options outstanding at March 28, 2015

  724,139    $ 47.01      5.5    $ 13,572   
  

 

 

          

Options exercisable at March 28, 2015

  495,239    $ 45.09      4.9    $ 10,232   
  

 

 

          

The total intrinsic value of stock options exercised during the thirteen-week periods ended March 28, 2015 and March 29, 2014 was $1,108,000 and $5,130,000, respectively.

As of March 28, 2015, there was $2,509,000 of total unrecognized compensation cost related to non-vested stock options granted under the Plans. The unrecognized compensation cost related to these non-vested options is expected to be recognized over a weighted average period of 2.0 years.

Non-vested Restricted Stock

The fair value of each share of non-vested restricted stock issued under the Plans is based on the fair value of a share of the Company’s common stock on the date of grant and shares of non-vested restricted stock are subject to vesting in three equal annual installments or 100% on the fifth anniversary of the date of the grant.

As of December 27, 2014, there were 23,353 shares of non-vested restricted stock outstanding with a weighted average grant date fair value of $54.90 per share. None of these shares vested or forfeited and no additional restricted stock shares were granted during the thirteen-week period ended March 28, 2015.

As of March 28, 2015, there was $710,000 of total unrecognized compensation cost related to non-vested shares of restricted stock granted under the Plans. The unrecognized compensation cost related to these non-vested shares of restricted stock is expected to be recognized over a weighted average period of 1.7 years.